Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea

NCT01124370 is registered in ClinicalTrials.gov with Respicardia, Inc. as lead sponsor.

NCT NCT01124370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01124370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Lead sponsor
Respicardia, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
August 31, 2014
Enrollment
57 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

central sleep apnea, cheyne stokes respiration, periodic breathing, sleep apnea, sleep disordered breathing